Human serum‐derived exosomes modulate macrophage inflammation to promote VCAM1‐mediated angiogenesis and bone regeneration

Abstract

During exogenous bone‐graft‐mediated bone defect repair, macrophage inflammation dictates angiogenesis and bone regeneration. Exosomes from different human cells have shown macrophage immunomodulation‐mediated bone regeneration potential. However, the effect of human serum‐derived exosomes (serum‐Exo) on macrophage immunomodulation‐mediated angiogenesis during bone defect repair has not been investigated yet. In this study, we explored the effects of serum‐Exo on macrophage inflammation regulation‐mediated angiogenesis during bone defect repair and preliminarily elucidated the mechanism. Healthy serum‐Exo was isolated by ultracentrifugation. The effect of serum‐Exo on LPS‐induced M1 macrophage inflammation was analysed in vitro. The conditioned medium of serum‐Exo‐treated LPS‐induced M1 macrophage (serum‐Exo‐treated M1 macrophage‐CM) was used to culture human umbilical vein endothelial cells (HUVEC), and the effect on angiogenesis was analysed by western blot, qRT‐PCR, etc. mRNA‐sequencing of HUVECs was performed to identify deferentially expressed genes. Finally, the rat mandibular defect model was established and treated with Bio‐Oss and Bio‐Oss + Exo. The effect of the Bio‐Oss + Exo combination on mandibular bone regeneration was observed by micro‐computed tomography (micro‐CT), haematoxylin and eosin (HE) staining, Masson staining, and immunohistochemical staining. Serum‐Exo promoted the proliferation of RAW264.7 macrophages and reduced the expression of M1‐related genes such as IL‐6, IL‐1β, iNOS, and CD86. Serum‐Exo‐treated M1 macrophage‐CM induced the proliferation, migration, and angiogenic differentiation of HUVEC, as well as the expression of H‐type blood vessel markers CD31 and endomucin (EMCN), compared with M1 macrophage‐CM. Moreover, higher expression of vascular endothelial adhesion factor 1 (VCAM1) in HUVEC cultured with serum‐Exo‐treated M1 macrophage‐CM compared with M1 macrophages‐CM. Inhibition of VCAM1 signalling abrogated the pro‐angiogenic effect of serum‐Exo‐treated M1 macrophage‐CM on HUVEC. Local administration of serum‐Exo during mandibular bone defect repair reduced the number of M1 macrophages and promoted angiogenesis and osteogenesis. Collectively, our results demonstrate the macrophage inflammation regulation‐mediated pro‐angiogenic potential of serum‐Exo during bone defect repair possibly via upregulation of VCAM1 signalling in HUVEC.

Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?

“…Furthermore, stimulating M2 macrophage phenotype by MSC-derived EVs may also improve ligament healing ( Chamberlain et al, 2021 ). Adipose tissue macrophages from lean mice release EVs that modulate macrophage polarization via contained miRNAs to promote wound healing in diabetic mice ( Xia et al, 2023 ), whereas human serum-derived EVs encouraged angiogenesis and osteogenesis by reducing the expression of M1-related genes in macrophages ( Xiang et al, 2023 ). Therapeutic EVs may also diminish the activity of M1 macrophages to alleviate periodontitis ( Luo et al, 2023 ).…”

Study on the mechanism of action of probucol in the treatment of coronary artery disease based on network pharmacology and molecular docking technology

“…When VCAM-1 is de cient, it can provoke the mobilization of neutrophils to be eliminated (Akbar et al, 2023). VCAM1 signalling in endothelial cells plays an important role in angiogenesis (Xiang et al, 2023). Atorvastatin and/or probucol lowers NF-κB levels, which resulted in the recovery of atherosclerosis in the ApoE -/mouse model (Guo et al, 2019).…”

MicroRNA-155 mediates multiple gene regulations pertinent to the role of human adipose-derived mesenchymal stem cells in skin regeneration

“…VCAM1 expression was found to be overexpressed at the wound edge at 48–96 h post injury in murine excisional wounds ( Roy et al, 2008 ). The pro-angiogenic effect of VCAM1 signalling was evident in bone defect repair when treated with human serum-derived exosomes as VCAM1 positively regulates vascular endothelial growth factor (VEGF) ( Xiang et al, 2023 ). In our experimental target analysis, the reported gene silencing effect of Anti-miR-155 on FGF2, FGF7, CCL2 and VCAM1 reverted to the basal level at 72 h as the method used for introducing miRNA to the cells was based on cationic-lipid transfection.…”